Evidence map›Paper›PMID 42183628›Full record

ArticleAutophagy2026

CHCHD2 and CHCHD10 promoted autophagic clearance of protein aggregates via GABARAPs.

Wei Zhou, Maggie Menglan Zhang, Willcyn Tang, Brijesh Kumar Singh, Zhiwei Zhang, Lei Zhou, Jaron Kim Wee Goh, Faith Rui En Tan, Jingxiu Huang, Qiaoyang Sun and 6 more

Abstract read
In one paragraph

Article in Autophagy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Wei ZhouDepartment of Research, National Neuroscience Institute, Singapore, Singapore.ORCID 0000-0002-0872-6223
Maggie Menglan ZhangSignature Research Program in Neuroscience and Behavioural Disorders, Duke-NUS Graduate Medical School, Singapore, Singapore.
Willcyn TangSignature Research Program in Neuroscience and Behavioural Disorders, Duke-NUS Graduate Medical School, Singapore, Singapore.ORCID 0000-0002-3739-1784
Brijesh Kumar SinghSignature Research Program in Cardiovascular and Metabolism Disorders, DUKE-NUS Graduate Medical School, Singapore, Singapore.ORCID 0000-0003-4615-3988
Zhiwei ZhangNeural Stem Cell Research Laboratory, Department of Research, National Neuroscience Institute, Singapore, Singapore.
Lei ZhouSchool of Optometry, Department of Applied Biology and Chemical Technology, Research Centre for SHARP Vision (RCSV), Hong Kong Polytechnic University, Hong Kong, China.
Jaron Kim Wee GohSchool of Life Sciences and Chemical Technology, Ngee Ann Polytechnic, Singapore, Singapore.
Faith Rui En TanSchool of Life Sciences and Chemical Technology, Ngee Ann Polytechnic, Singapore, Singapore.
Jingxiu HuangSignature Research Program in Neuroscience and Behavioural Disorders, Duke-NUS Graduate Medical School, Singapore, Singapore.
Qiaoyang SunDepartment of Research, National Neuroscience Institute, Singapore, Singapore.ORCID 0000-0002-7842-7034
Bin XiaoDepartment of Research, National Neuroscience Institute, Singapore, Singapore.
Gupta PriyankaSignature Research Program in Cardiovascular and Metabolism Disorders, DUKE-NUS Graduate Medical School, Singapore, Singapore.
Alfred Xuyang SunDepartment of Research, National Neuroscience Institute, Singapore, Singapore.ORCID 0000-0002-7893-2006
Li ZengNeural Stem Cell Research Laboratory, Department of Research, National Neuroscience Institute, Singapore, Singapore.ORCID 0000-0003-3242-2286
Han-Ming ShenFaculty of Health Sciences, Ministry of Education Frontiers Science Centre for Precision Oncology, University of Macau, Macau, China.ORCID 0000-0001-7369-5227
Eng King TanDepartment of Research, National Neuroscience Institute, Singapore, Singapore.ORCID 0000-0003-2977-9743

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in mitochondrial protein CHCHD2 and its paralog CHCHD10 were identified in patients with Parkinson disease (PD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) or Alzheimer disease (AD). CHCHD2 and CHCHD10 mutations caused neurodegeneration in model animals as seen in patients, but their pathophysiological roles remain elusive. Here we reported a direct role of CHCHD2 and CHCHD10 in autophagy. We identified a protein complex composing of CHCHD2-CHCHD10-C1QBP/p32-Atg8-family proteins (ATG8s), in which each molecule interacted with another. CHCHD2, CHCHD10 and C1QBP/p32 associated with ATG8s, preferentially, GABARAPs. Disease-associated CHCHD2 and CHCHD10 mutations exhibited varied interaction with ATG8s. By binding to GABARAPs, CHCHD2 and CHCHD10 underwent autophagic degradation, and recruited the ULK1 complex. Autophagy initiation defects occurred upon transient knockdown of

Indexed as

Apoptosis Regulatory ProteinsAutophagyMicrotubule-Associated ProteinsMitochondrial ProteinsProtein AggregatesTranscription FactorsAnimalsDNA-Binding ProteinsHumansMiceMutationApoptosis Regulatory ProteinsCHCHD10 protein, humanCHCHD2 protein, humanDNA-Binding ProteinsGABARAP protein, humanMicrotubule-Associated ProteinsMitochondrial ProteinsProtein AggregatesTranscription FactorsAggregatesautophagyCHCHD10CHCHD2GABARAPsneurodegeneration

Identifiers

PMID42183628
PMCPMC13618842

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.